Cancer research
A new study published in Clinical Cancer Research has highlighted the effectiveness of a novel approach to lung cancer therapy. Researchers from the University of Colorado, led by S. Sundaram, have developed a targeted drug and gene delivery system that combines deslorelin, a luteinizing hormone-releasing hormone agonist, with docetaxel, a
Cancer research
Researchers have discovered synergistic antitumor effects when combining iodine-131 labeled monoclonal antibody LC-1 with interleukin-12 (IL-12) vaccine on Lewis lung carcinoma tumors. A study published in International Immunopharmacology found that the combination of both treatments inhibited tumor growth more effectively than either treatment alone. The researchers used a mouse model
Cancer
Malignant glioma, one of the most aggressive cancers, requires effective therapeutic strategies for treatment. Researchers in Suita, Japan, have made a significant discovery in elucidating molecular targets for such diseases. A study published in the International Journal of Cancer Journal International Du Cancer has revealed the role of sterile alpha
Cancer
Researchers from the United States have made a significant discovery in the fight against glioblastoma multiforme, the most common primary intracranial malignancy. Despite advances in surgical techniques and chemo-and radiation therapy, the outcome for patients with this disease remains poor. The study, published in Cancer Letters, explores the potential of
Cancer
Researchers at Niigata, Japan's The Nippon Dental University have made significant breakthroughs in the field of cancer gene therapy, specifically targeting oral cancer. Their experimental study, published in Odontology, aimed to investigate the effectiveness of an antiangiogenic gene therapy that inhibits the growth of new blood vessels that
Cancer research
Scientists at the University of Illinois have discovered a novel approach to treating breast cancer by delivering quinone warheads to DNA via a selective estrogen receptor modulator (SERM), triggering apoptosis in estrogen receptor-positive (ER+) breast cancer cells. This breakthrough study, published in ACS Chemical Biology, demonstrates the potential for a
Cancer research
Breast cancer cells have an increased expression of the Ca(2+)-sensing receptor (CaR) and Galpha(12), which plays a crucial role in the regulation of multiple signaling pathways in response to extracellular Ca2+. The activation of choline kinase (ChoK) by extracellular Ca2+ is a significant event in breast cancer
Cancer
Peritoneal dissemination of gastric cancer is a challenging condition that is often resistant to systemic therapies. Researchers in Japan have made a significant breakthrough in developing a novel adenoviral oncolytic suicide gene therapy that targets carcinoembryonic antigen (CEA) to treat this condition. The new system, which consists of three types
Cancer
Researchers at the University of Liverpool have reported promising results in a study investigating the use of siRNA therapy delivered by atelocollagen to target the FABP5 gene in prostate cancer. The study, published in International Journal of Oncology, aimed to test the hypothesis that siRNA targeting FABP5 could reduce the
Cancer research
Researchers from the Third Military Medical University in Chongqing, People's Republic of China, have made significant strides in the development of photodynamic therapy (PDT) for cancer treatment. By combining PDT with gene therapy, targeted at the apurinic/apyrimidinic endonuclease 1 (APE1) protein, they have shown improved efficacy in
Cancer research
Cancer gene therapy researchers in Iran have discovered a new approach to enhancing the sensitivity of human colon cancer cells to radiation by targeting the insulin-like growth factor receptor 1 (IGF-1R). The study, published in Acta Oncologica, used a specific small interference RNA (siRNA) expression vector to inhibit IGF-1R mRNA
Cancer
Researchers at the Technical University of Munich have made a breakthrough in the treatment of prostate cancer using immunotherapy with whole cell cancer vaccines. In a phase I/II trial, 30 patients with progressive and castration-resistant prostate cancer were injected with an allogeneic prostate carcinoma cell line expressing recombinant human
